Raynaud's phenomenon secondary to central nervous system stimulants: A therapeutic role of α-1 adrenergic blockers?

Semin Arthritis Rheum. 2022 Dec:57:152115. doi: 10.1016/j.semarthrit.2022.152115. Epub 2022 Oct 26.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adrenergic Antagonists
  • Central Nervous System Stimulants*
  • Humans
  • Raynaud Disease* / drug therapy
  • Raynaud Disease* / etiology

Substances

  • Central Nervous System Stimulants
  • Adrenergic Antagonists